Terms: = Endocrine gland cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Diagnosis
10 results:
1. Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Møller NB; Boonen DS; Feldner ES; Hao Q; Larsen M; Lænkholm AV; Borg Å; Kvist A; Törngren T; Jensen UB; Boonen SE; Thomassen M; Terkelsen T
Sci Rep; 2023 May; 13(1):8536. PubMed ID: 37237042
[TBL] [Abstract] [Full Text] [Related]
2. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.
He Z; Wang J; Zhu C; Xu J; Chen P; Jiang X; Chen Y; Jiang J; Sun C
Cancer Lett; 2022 Nov; 548():215751. PubMed ID: 35718269
[TBL] [Abstract] [Full Text] [Related]
3. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
4. Epidemiology of HPB malignancy in the elderly.
Pericleous M; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):503-513. PubMed ID: 32360064
[TBL] [Abstract] [Full Text] [Related]
5. Multiparametric MRI Evaluation of Complex Ovarian Masses.
Singla V; Dawadi K; Singh T; Prabhakar N; Srinivasan R; Suri V; Khandelwal N
Curr Probl Diagn Radiol; 2021; 50(1):34-40. PubMed ID: 31399230
[TBL] [Abstract] [Full Text] [Related]
6. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract] [Full Text] [Related]
7. Inherited predisposition to breast cancer among African American women.
Churpek JE; Walsh T; Zheng Y; Moton Z; Thornton AM; Lee MK; Casadei S; Watts A; Neistadt B; Churpek MM; Huo D; Zvosec C; Liu F; Niu Q; Marquez R; Zhang J; Fackenthal J; King MC; Olopade OI
Breast Cancer Res Treat; 2015 Jan; 149(1):31-9. PubMed ID: 25428789
[TBL] [Abstract] [Full Text] [Related]
8. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract] [Full Text] [Related]
9. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract] [Full Text] [Related]
10. Carcinoma showing thymus-like element (CASTLE) of thyroid: combined modality treatment in 3 patients with locally advanced disease.
Chow SM; Chan JK; Tse LL; Tang DL; Ho CM; Law SC
Eur J Surg Oncol; 2007 Feb; 33(1):83-5. PubMed ID: 17085008
[TBL] [Abstract] [Full Text] [Related]
